NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyVulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01)
National Institutes of Health
About This Grant
Purpose. This Funding Opportunity Announcement (FOA)issued by the National Institute of Child Health and Human Development (NICHD) and the Office of Research on Women s Health (ORWH), National Institutes of Health (NIH), solicits investigator-initiated applications that address basic, clinical, translational, epidemiological and/or behavioral research that concentrates on studies of relevance to vulvodynia and that advance prevention and therapeutic opportunities Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Eligible Institutions/Organizations. Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Other(s): Eligible agencies of the Federal government; Faith-based or community based organizations .
Grant Summary
Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01) is a National Institutes of Health grant providing funding that varies by award for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $0K
Rolling / Open
- 1Confirm your organization is eligible for Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01): Frequently Asked Questions
Who is eligible for the Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01)?
Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01) provide?
Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01) provides an amount that varies by award per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01) deadline?
Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01)?
To apply for Vulvodynia - Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.